Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation
NCT ID: NCT03975725
Last Updated: 2019-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2019-09-30
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is therefore to demonstrate that at least 90 +/- 0.03% of ECGWs are interpretable by a physician and the primary endpoint will therefore be the ratio of the number of ECGWs that allowed a physician to make a diagnosis. rhythmic (ECGW interpretable) and the total number of ECGW recorded and viewed.
The clinical trial as part of the CE medical device certification process for secondary objectives and ancillary studies will be required to assess the diagnostic performance of the WitCard + WitDisplayer system, the quality of the ECGW recorded by the WitCard, the the safety of using the WitCard, the technical performance of the WitCard ECG recorder, the ergonomics of the WitCard, and finally the performance of automatic cardiac rhythm classification algorithms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Withings Move ECG Software for Atrial Fibrillation Detection
NCT04493749
Validation Study of WITHINGS BPM Core for the Detection of Atrial Fibrillation
NCT04464499
Use of the ECG Watch in Palpitation Assessment: Feasibility Study
NCT07121816
Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch
NCT04176926
A Wearable With Photoplethysmography and 6-lead Electrocardiography for Atrial Fibrillation Detection
NCT04281927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
witcard
the use of the WitCard
electrocardiogram (ECG)
the use of WitDisplayer
a software to visualize, measure, annotate, comment, archive, and share the different ECGs acquired with the WitCard (ECGW) of different patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the use of the WitCard
electrocardiogram (ECG)
the use of WitDisplayer
a software to visualize, measure, annotate, comment, archive, and share the different ECGs acquired with the WitCard (ECGW) of different patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Palpitations
* Dyspnoea, acute pulmonary edema, non-ischemic heart failure
* Malaise, lipothymia, syncope
Exclusion Criteria
* Immediate vital risk whatever its nature
* Rhythmic urgency requiring treatment without delay: respiratory, circulatory or neurological distress
* Acute Coronary Syndrome
* Pregnant women
* Non-beneficiaries of a social security scheme
* Persons deprived of their liberty
* Patient participating in another study
* Patient in a period of exclusion determined by a previous study
* Patient under the protection of justice, under guardianship or under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jean-olivier ARNAUD
Role: STUDY_DIRECTOR
Assistance Publique Hopitaux De Marseille
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A00918-49
Identifier Type: OTHER
Identifier Source: secondary_id
2018-67
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.